Unknown

Dataset Information

0

Impact of Comorbidities on Health-related Quality of Life in Nontransplant Eligible Patients With Newly Diagnosed Multiple Myeloma.

ABSTRACT:

SUBMITTER: Bennink MC 

PROVIDER: S-EPMC9263484 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Optimizing outcomes for patients with newly diagnosed multiple myeloma eligible for transplantation.
| S-EPMC4851188 | biostudies-literature
Unknown The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma.
| S-EPMC7764080 | biostudies-literature
Unknown Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
| S-EPMC7441167 | biostudies-literature
Unknown Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial.
| S-EPMC8078427 | biostudies-literature
Unknown Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project.
| S-EPMC6251924 | biostudies-literature
Transcriptomics Expression data of newly diagnosed multiple myeloma and extramedullary myeloma
2023-03-01 | GSE147841 | GEO
Unknown Daratumumab in untreated newly diagnosed multiple myeloma.
| S-EPMC6928545 | biostudies-literature
Unknown Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.
| S-EPMC8699806 | biostudies-literature
Genomics Hydroxymethylation in newly diagnosed Multiple Myeloma
| PRJEB32800 | ENA
Unknown Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.
| S-EPMC8170980 | biostudies-literature